Video: Ncardia’s iPSC technology

Posted: 3 July 2020 | | No comments yet

This Ncardia company presentation will explain how human stem cell technology offers a solution for drug screening as well as cell therapy projects.

Human stem cell biology is ideally suited for drug screening as well as cell therapy. We work with clients to develop cardiac and cns disease models and optimised assay systems to enable efficacy testing that better translate to the clinic. Our robust Manufacturing Platform allows liter-scale batches of high quality, functional cells. For post-manufacturing analysis, Ncardia has an extensive selection of instrumentation for identity verification as well as functional characterisation.


Related organisations

Leave a Reply

Your email address will not be published. Required fields are marked *